- £836.55m
- £1.14bn
- £712.80m
Annual income statement for CVS, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2022 June 30th | R2023 June 30th | C2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 554 | 589 | 639 | 673 | 713 |
| Cost of Revenue | |||||
| Gross Profit | 239 | 258 | 269 | 286 | 316 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 511 | 521 | 591 | 623 | 665 |
| Operating Profit | 42.8 | 68.4 | 47.8 | 49.8 | 47.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 36 | 60.7 | 35.2 | 32.6 | 32 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 25.7 | 48.1 | 24.7 | 19.1 | 17.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 25.7 | 41.9 | 6.2 | 52.8 | 17.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 25.7 | 41.9 | 6.2 | 52.8 | 17.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.48 | 0.718 | 0.484 | 0.357 | 0.357 |
| Dividends per Share |